{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:31:37Z","timestamp":1792459897541,"version":"4.5.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.42780","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T11:03:11Z","timestamp":1641812591000},"page":"e2142780","source":"Crossref","is-referenced-by-count":130,"title":["Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody\u2013Associated Disease in the United Kingdom"],"prefix":"10.1001","volume":"5","author":[{"given":"Chanjira","family":"Satukijchai","sequence":"first","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom"},{"name":"Neuroscience Center, Bangkok International Hospital, Bangkok, Thailand"},{"name":"Division of Neurology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Mariano","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Messina","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom"},{"name":"Department of Clinical Neurology, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sa","sequence":"additional","affiliation":[{"name":"Paediatric Neurology, Great Ormond Street Hospital for Children, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Woodhall","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil P.","family":"Robertson","sequence":"additional","affiliation":[{"name":"Department of Neurology, Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lim","family":"Ming","sequence":"additional","affiliation":[{"name":"Children\u2019s Neurosciences, Evelina London Children\u2019s Hospital at Guy\u2019s and St Thomas\u2019 National Health Service Foundation Trust, London, United Kingdom"},{"name":"Department of Women and Children\u2019s Health, School of Life Course Sciences, King\u2019s College London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangeline","family":"Wassmer","sequence":"additional","affiliation":[{"name":"Birmingham Women\u2019s and Children\u2019s National Health Service Foundation Trust, Birmingham, United Kingdom"},{"name":"School of Life and Health Sciences, Aston University, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kneen","sequence":"additional","affiliation":[{"name":"Alder Hey Children's National Health Service Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Huda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Walton Centre National Health Service Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Jacob","sequence":"additional","affiliation":[{"name":"Department of Neurology, Walton Centre National Health Service Foundation Trust, Liverpool, United Kingdom"},{"name":"Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Blain","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals National Health Service Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Halfpenny","sequence":"additional","affiliation":[{"name":"University Hospitals Southampton National Health Service Foundation Trust, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Hemingway","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Great Ormond Street Hospital for Children, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin","family":"O'Sullivan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kings College Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hobart","sequence":"additional","affiliation":[{"name":"Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, United Kingdom"},{"name":"University Hospitals Plymouth National Health Service Foundation Trust, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonora K.","family":"Fisniku","sequence":"additional","affiliation":[{"name":"University Hospitals Sussex National Health Service Foundation Trust, Brighton, United Kingdom"},{"name":"Brighton and Sussex Medical School, Brighton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roswell","family":"Martin","sequence":"additional","affiliation":[{"name":"Gloucestershire Hospitals National Health Service Foundation Trust, Gloucestershire, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Dopson","sequence":"additional","affiliation":[{"name":"Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, United Kingdom"},{"name":"Royal London Hospital, Barts Health National Health Service Foundation Trust, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Cooper","sequence":"additional","affiliation":[{"name":"University Hospitals Sussex National Health Service Foundation Trust, Brighton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Williams","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 National Health Service Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Waters","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sithara","family":"Ramdas","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Leite","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom"},{"name":"Department of Clinical Neurology, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom"},{"name":"Department of Clinical Neurology, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"issue":"8","key":"zoi211189r1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases.","volume":"9","author":"Reindl","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"zoi211189r2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/brain\/aww350","article-title":"Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"issue":"11","key":"zoi211189r3","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1136\/jnnp-2015-312676","article-title":"Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.","volume":"87","author":"Kaneko","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"zoi211189r4","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1177\/1352458514566666","article-title":"Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort.","volume":"21","author":"Ketelslegers","year":"2015","journal-title":"Mult Scler"},{"issue":"5","key":"zoi211189r5","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000257","article-title":"Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis.","volume":"3","author":"Spadaro","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"zoi211189r6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"zoi211189r7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"issue":"6","key":"zoi211189r8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"zoi211189r9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-019-1525-1","article-title":"Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease.","volume":"16","author":"Cobo-Calvo","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"1","key":"zoi211189r10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/ana.v89.1","article-title":"Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease.","volume":"89","author":"Cobo-Calvo","year":"2021","journal-title":"Ann Neurol"},{"issue":"12","key":"zoi211189r11","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study.","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"issue":"12","key":"zoi211189r12","first-page":"1381","article-title":"Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka.","volume":"90","author":"Senanayake","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"zoi211189r13","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1177\/1352458516631038","article-title":"Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases.","volume":"22","author":"Baumann","year":"2016","journal-title":"Mult Scler"},{"issue":"2","key":"zoi211189r14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/1352458515587751","article-title":"Clinical and MRI phenotype of children with MOG antibodies.","volume":"22","author":"Fernandez-Carbonell","year":"2016","journal-title":"Mult Scler"},{"issue":"1","key":"zoi211189r15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes.","volume":"77","author":"Waters","year":"2020","journal-title":"JAMA Neurol"},{"issue":"10","key":"zoi211189r16","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1136\/jnnp-2020-323158","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK.","volume":"91","author":"O\u2019Connell","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"zoi211189r17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","article-title":"Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease.","volume":"75","author":"Hacohen","year":"2018","journal-title":"JAMA Neurol"},{"issue":"1","key":"zoi211189r18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11940-019-0541-x","article-title":"Treatment approaches for MOG-Ab-associated demyelination in children.","volume":"21","author":"Hacohen","year":"2019","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"zoi211189r19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients: part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"2","key":"zoi211189r20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"zoi211189r21","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"zoi211189r22","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1212\/WNL.0000000000007096","article-title":"A multicenter comparison of MOG-IgG cell-based assays.","volume":"92","author":"Waters","year":"2019","journal-title":"Neurology"},{"issue":"21","key":"zoi211189r23","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study.","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"zoi211189r24","article-title":"MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response.","volume":"4","author":"Pandit","year":"2018","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"9","key":"zoi211189r26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis.","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"key":"zoi211189r25","unstructured":"Ethnicity facts and figures. Gov.UK. Accessed December 10, 2020. https:\/\/www.ethnicity-facts-figures.service.gov.uk\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2787769\/satukijchai_2022_oi_211189_1646749435.32707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T20:24:45Z","timestamp":1726431885000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2787769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.42780","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]}}}